2 Biotech Cos. Launch IPOs Despite Erratic Market Conditions
Two biotechnology companies on Wednesday set price ranges on initial public offerings that are expected to raise $125 million combined, opting to move forward on IPOs in a stock market that...To view the full article, register now.
Already a subscriber? Click here to view full article